Patents by Inventor Matthew Downham

Matthew Downham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment For M Treatment For Multiple Sclerosis
    Publication number: 20120116059
    Abstract: The present invention relates to methods for the treatment and/or prophylaxis of multiple sclerosis (MS). Antagonists of GM-CSF, such as antibodies specific for GM-CSF or the GM-CSF receptor, are effective in the treatment and/or prophylaxis of multiple sclerosis.
    Type: Application
    Filed: May 4, 2010
    Publication date: May 10, 2012
    Applicant: MORPHOSYS AG
    Inventors: Stefan Steidl, Manuela Duerr, Elisabeth Thomassen-Wolf, Matthew Downham, Robert Friesen
  • Immunogenic conjugates
    Publication number: 20060110400
    Abstract: The invention relates to an immunogenic conjugate comprising at least one vascular endothelial growth factor (VEGF) peptide moiety coupled to a carrier.
    Type: Application
    Filed: June 17, 2003
    Publication date: May 25, 2006
    Applicant: PROTHERICS PLC
    Inventors: James Glover, Matthew Downham, Ajaz Rosul, Deborah Spencer, Iain Hargrave